Skip to main content
. 2021 Jan 4;11(1):69. doi: 10.3390/diagnostics11010069

Figure 1.

Figure 1

Plasma annexin A2 levels in patients with OC, benign ovarian tumors and healthy controls. Box and whisker plots representing annexin A2 levels measured in stage IA (n = 15), stage IA-IC (n = 32), stage II (n = 17) and stage III-IV (n = 56) OC, benign ovarian tumors (n = 55) and healthy controls (n = 143). Median values for plasma annexin A2: stage IA (115.3 ng/mL, range: 35.7–379.7), stage IA-IC (114.2 ng/mL, range: 35.7–499.1), stage II (93.6 ng/mL, range: 42.6–354.7), stage III-IV (76.2 ng/mL, range: 36.1–194.9) OC, benign ovarian tumors (63.5 ng/mL, range: 31.1–246.1) and healthy controls (62.7 ng/mL, range: 24.2–224.3). Comparison between patient groups was performed by Kruskal–Wallis and Dunn’s multiple comparison tests. (ns = not significant, * p value < 0.05, ** p value < 0.01, *** p value < 0.001, **** p value < 0.0001).